Aceruloplasminemia presents as Type 1 diabetes in non-obese adults: A detailed case series

Diabetic Medicine

Volumn 32, Issue 8, 2015, Pages 993-1000

  Vroegindeweij, L H P ^a   van der Beek, E H ^a   Boon, A J W ^a   Hoogendoorn, M ^b   Kievit, J A ^a   Wilson, J H P ^a   Langendonk, J G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; FERRITIN; HEMOGLOBIN A1C; TRANSFERRIN;

ACERULOPLASMINEMIA; ADULT; ANEMIA; AUTOPSY; AUTOSOMAL RECESSIVE DISORDER; BRONCHOPNEUMONIA; CASE REPORT; CERULOPLASMIN BLOOD LEVEL; EXON; FERRITIN BLOOD LEVEL; FOLLOW UP; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HYPERFERRITINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTRON; IRON CHELATION; MALE; MEAN CORPUSCULAR VOLUME; MIDDLE AGED; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; COMPLICATION; CONSANGUINITY; DEFICIENCY; DIABETES MELLITUS, TYPE 1; GENETICS; IRON METABOLISM DISORDERS; NEURODEGENERATIVE DISEASES;

CERULOPLASMIN; CONSANGUINITY; DIABETES MELLITUS, TYPE 1; HUMANS; IRON METABOLISM DISORDERS; MALE; MIDDLE AGED; NEURODEGENERATIVE DISEASES;

EID: 84948715085     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12712     Document Type: Review

References (50)

1. Miyajima H, Takahashi Y, Kono S. Aceruloplasminemia, an inherited disorder of iron metabolism. Biometals 2003; 16: 205-213.
2. Kono S, Miyajima H. Molecular and pathological basis of aceruloplasminemia. Biol Res 2006; 39: 15-23.
3. McNeill A, Pandolfo M, Kuhn J, Shang H, Miyajima H. The neurological presentation of ceruloplasmin gene mutations. Eur Neurol 2008; 60: 200-205.
4. Fasano A, Colosimo C, Miyajima H, Tonali PA, Re TJ, Bentivoglio AR. Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability. Mov Disord 2008; 23: 751-755.
5. Hellman NE, Kono S, Mancini GM, Hoogeboom AJ, De Jong GJ, Gitlin JD. Mechanisms of copper incorporation into human ceruloplasmin. J Biol Chem 2002; 277: 46632-46638.
6. Kerkhof M, Honkoop P. Never forget aceruloplasminemia in case of highly suggestive Wilson's disease score. Hepatology 2014; 59: 1645-1647.
7. Bethlehem C, van Harten B, Hoogendoorn M. Central nervous system involvement in a rare genetic iron overload disorder. Neth J Med 2010; 68: 316-318.
8. Bosio S, De Gobbi M, Roetto A, Zecchina G, Leonardo E, Rizzetto M et al. Anemia and iron overload due to compound heterozygosity for novel ceruloplasmin mutations. Blood 2002; 100: 2246-2248.
9. Chretien F, Servan J, Mikol J, Trierweiller M, Elghozi D, Gray F. A 70-year-old man with extrapyramidal symptoms, dementia and hemosiderosis. Brain Pathol 2006; 16: 235-236.
10. Daimon M, Kato T, Kawanami T, Tominaga M, Igarashi M, Yamatani K et al. A nonsense mutation of the ceruloplasmin gene in hereditary ceruloplasmin deficiency with diabetes mellitus. Biochem Biophys Res Commun 1995; 217: 89-95.
11. Di Raimondo D, Pinto A, Tuttolomondo A, Fernandez P, Camaschella C, Licata G. Aceruloplasminemia: a case report. Intern Emerg Med 2008; 3: 395-399.
12. Dunaief JL, Richa C, Franks EP, Schultze RL, Aleman TS, Schenck JF et al. Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload. Ophthalmology 2005; 112: 1062-1065.
13. Finkenstedt A, Wolf E, Höfner E, Gasser BI, Bösch S, Bakry R et al. Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation. J Hepatol 2010; 53: 1101-1107.
14. Fujita K, Osaki Y, Harada M, Kono S, Miyajima H, Izumi Y et al. Brain and liver iron accumulation in aceruloplasminemia. Neurology 2013; 81: 2145-2146.
15. Haemers I, Kono S, Goldman S, Gitlin JD, Pandolfo M. Clinical, molecular, and PET study of a case of aceruloplasminaemia presenting with focal cranial dyskinesia. J Neurol Neurosurg Psychiatry 2004; 75: 334-337.
16. Hatanaka Y, Okano T, Oda K, Yamamoto K, Yoshida K. Aceruloplasminemia with juvenile-onset diabetes mellitus caused by exon skipping in the ceruloplasmin gene. Intern Med 2003; 42: 599-604.
17. Hellman NE, Schaefer M, Gehrke S, Stegen P, Hoffman WJ, Gitlin JD et al. Hepatic iron overload in aceruloplasminaemia. Gut 2000; 47: 858-860.
18. Hida A, Kowa H, Iwata A, Tanaka M, Kwak S, Tsuji S. Aceruloplasminemia in a Japanese woman with a novel mutation of CP gene: clinical presentations and analysis of genetic and molecular pathogenesis. J Neurol Sci 2010; 298: 136-139.
19. Hofmann WP, Welsch C, Takahashi Y, Miyajima H, Mihm U, Krick C et al. Identification and in silico characterization of a novel compound heterozygosity associated with hereditary aceruloplasminemia. Scand J Gastroenterol 2007; 42: 1088-1094.
20. Kohno S, Miyajima H, Takahashi Y, Inoue Y. Aceruloplasminemia with a novel mutation associated with parkinsonism. Neurogenetics 2000; 2: 237-238.
21. Kono S, Suzuki H, Takahashi K, Takahashi Y, Shirakawa K, Murakawa Y et al. Hepatic iron overload associated with a decreased serum ceruloplasmin level in a novel clinical type of aceruloplasminemia. Gastroenterology 2006; 131: 240-245.
22. Logan JI, Harveyson KB, Wisdom GB, Hughes AE, Archbold GP. Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus. QJM 1994; 87: 663-670.
23. Loreal O, Turlin B, Pigeon C, Moisan A, Ropert M, Morice P et al. Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights. J Hepatol 2002; 36: 851-856.
24. Mariani R, Arosio C, Pelucchi S, Grisoli M, Piga A, Trombini P et al. Iron chelation therapy in aceruloplasminaemia: study of a patient with a novel missense mutation. Gut 2004; 53: 756-758.
25. Matsushima A, Yoshida T, Yoshida K, Ohara S, Toyoshima Y, Kakita A et al. Superficial siderosis associated with aceruloplasminemia Case report. J Neurol Sci 2014; 339: 231-234.
26. Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 1987; 37: 761-767.
27. Miyajima H, Takahashi Y, Kono S, Hishida A, Ishikawa K, Sakamoto M. Frontal lobe dysfunction associated with glucose hypometabolism in aceruloplasminemia. J Neurol 2005; 252: 996-997.
28. Morita H, Ikeda S, Yamamoto K, Morita S, Yoshida K, Nomoto S et al. Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol 1995; 37: 646-656.
29. Muroi R, Yagyu H, Kobayashi H, Nagata M, Sato N, Ideno J et al. Early onset insulin-dependent diabetes mellitus as an initial manifestation of aceruloplasminaemia. Diabet Med 2006; 23: 1136-1139.
30. Ogimoto M, Anzai K, Takenoshita H, Kogawa K, Akehi Y, Yoshida R et al. Criteria for early identification of aceruloplasminemia. Intern Med 2011; 50: 1415-1418.
31. Okamoto N, Wada S, Oga T, Kawabata Y, Baba Y, Habu D et al. Hereditary ceruloplasmin deficiency with hemosiderosis. Hum Genet 1996; 97: 755-758.
32. Parks NE, Vandorpe RA, Moeller JJ. Teaching NeuroImages: neurodegeneration with brain iron accumulation in aceruloplasminemia. Neurology 2013; 81: e151-e152.
33. Pérez-Aguilar F, Burguera JA, Benlloch S, Berenguer M, Rayón JM. Aceruloplasminemia in an asymptomatic patient with a new mutation. Diagnosis and family genetic analysis. J Hepatol 2005; 42: 947-949.
34. Roberti Mdo R, Borges Filho HM, Goncalves CH, Lima FL. Aceruloplasminemia: a rare disease - diagnosis and treatment of two cases. Rev Bras Hematol Hemoter 2011; 33: 389-392.
35. Rusticeanu M, Zimmer V, Schleithoff L, Wonney K, Viera J, Zimmer A et al. Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms. Clin Genet 2014; 85: 300-301.
36. Shang HF, Jiang XF, Burgunder JM, Chen Q, Zhou D. Novel mutation in the ceruloplasmin gene causing a cognitive and movement disorder with diabetes mellitus. Mov Disord 2006; 21: 2217-2220.
37. Skidmore FM, Drago V, Foster P, Schmalfuss IM, Heilman KM, Streiff RR. Aceruloplasminaemia with progressive atrophy without brain iron overload: treatment with oral chelation. J Neurol Neurosurg Psychiatry 2008; 79: 467-470.
38. Suzuki Y, Yoshida K, Aburakawa Y, Kuroda K, Kimura T, Terada T et al. Effectiveness of oral iron chelator treatment with deferasirox in an aceruloplasminemia patient with a novel ceruloplasmin gene mutation. Intern Med 2013; 52: 1527-1530.
39. Tai M, Matsuhashi N, Ichii O, Suzuki T, Ejiri Y, Kono S et al. Case of presymptomatic aceruloplasminemia treated with deferasirox. Hepatol Res 2014; 44: 1253-1258.
40. Takahashi Y, Miyajima H, Shirabe S, Nagataki S, Suenaga A, Gitlin JD. Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease. Hum Mol Genet 1996; 5: 81-84.
41. Takeuchi Y, Yoshikawa M, Tsujino T, Kohno S, Tsukamoto N, Shiroi A et al. A case of aceruloplasminaemia: abnormal serum ceruloplasmin protein without ferroxidase activity. J Neurol Neurosurg Psychiatry 2002; 72: 543-545.
42. Watanabe M, Asai C, Ishikawa K, Kiyota A, Terada T, Kono S et al. Central diabetes insipidus and hypothalamic hypothyroidism associated with aceruloplasminemia. Intern Med 2010; 49: 1581-1585.
43. Yazaki M, Yoshida K, Nakamura A, Furihata K, Yonekawa M, Okabe T et al. A novel splicing mutation in the ceruloplasmin gene responsible for hereditary ceruloplasmin deficiency with hemosiderosis. J Neurol Sci 1998; 156: 30-34.
44. Grisoli M, Piperno A, Chiapparini L, Mariani R, Savoiardo M. MR imaging of cerebral cortical involvement in aceruloplasminemia. AJNR Am J Neuroradiol 2005; 26: 657-661.
45. Miyajima H, Kohno S, Takahashi Y, Yonekawa O, Kanno T. Estimation of the gene frequency of aceruloplasminemia in Japan. Neurology 1999; 53: 617-619.
46. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014; 37 S81-S90.
47. Ellervik C, Birgens H, Mandrup-Poulsen T. Need for reclassification of diabetes secondary to iron overload in the ADA and WHO classifications. Diabetes Care 2014; 37: e137-e138.
48. Nittis T, Gitlin JD. The copper-iron connection: hereditary aceruloplasminemia. Semin Hematol 2002; 39: 282-289.
49. Hahn JU, Steiner M, Bochnig S, Schmidt H, Schuff-Werner P, Kerner W. Evaluation of a diagnostic algorithm for hereditary hemochromatosis in 3, 500 patients with diabetes. Diabetes Care 2006; 29: 464-466.
50. Ellervik C, Mandrup-Poulsen T, Nordestgaard BG, Larsen LE, Appleyard M, Frandsen M et al. Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study. Lancet 2001; 358: 1405-1409.